Milwaukee, Wisconsin
October 8, 2007
EMD Crop BioScience
Inc. has hired Cathy Soanes as North American Marketing
Manager.
Soanes brings a long and successful history working in the North
American seed industry, from research through to the marketing
side of the business. “The depth and breadth of her knowledge
will be key in helping the company achieve its marketing goals,”
says Dr. Scott Fleetwood, Vice President of Sales and Marketing
for EMD Crop BioScience Inc.
Most recently, Soanes served as the Marketing Services and
Communications Manager for NK Brand Syngenta Seeds, Inc. in
Minnesota. “Cathy impressed us with her understanding of the
marketplace, her strategic thinking and her brand management
skills,” says Fleetwood. “She is a very strong addition to our
marketing team.”
In her new role, Soanes will be responsible for market
development in Canada and the Northern U.S. “I think EMD Crop
BioScience is in a unique position, with unique technology that
will help revolutionize the whole concept of adding value to
seed and crops,” says Soanes. “The next few years are going to
be an exciting time for the company.”
Originally founded as the Nitragin Company in 1898 after a
Milwaukee entrepreneur purchased rights to a commercial process
for the production of nitrogen-fixing rhizobia, Nitragin
remained privately owned until 1982. In 1991 Merck KGaA,
Darmstadt, Germany purchased the business. Now headquartered in
Milwaukee, Wisconsin, EMD Crop BioScience is committed to
advancing crop-enhancing technologies and making these products
available to growers worldwide.
Merck is a global pharmaceutical and chemical company with sales
of EUR 6.3 billion in 2006, a history that began in 1668, and a
future shaped by 30,000 employees in 63 countries. Its success
is characterized by innovations from entrepreneurial employees.
Merck's operating activities come under the umbrella of Merck
KGaA, in which the Merck family holds an approximately 70%
interest and free shareholders own the remaining approximately
30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated
and has been an independent company ever since. |
|
